DR. JEFFREY H LAWSON, M.D.
Radiology at Roxboro St, Durham, NC
License number
North Carolina 99-00913
Category
Radiology
Type
Surgery
Address
Address
4101 N Roxboro St, Durham, NC 27704
Phone
(919) 684-8111
Organization information
See more information about JEFFREY H LAWSON at bizstanding.comDuke University Medical Center - Jeffrey H Lawson MD
2616 Erwin Rd, Durham, NC 27705
Categories:
General Surgeons
Site:
Phone:
(919) 681-2533 (Phone)
Jeffrey H Lawson MD
2000 Erwin Rd #2B, Durham, NC 27705
Categories:
Physicians & Surgeons
Phone:
(919) 681-6432 (Phone)
Professional information
Dr. Jeffrey H Lawson, Durham NC - MD (Doctor of Medicine)
Specialties:
General Surgery, Vascular Surgery
Address:
Durham Office
1 Duke Medical Ctr, Durham 27710
(919) 684-8111 (Phone), (919) 681-8679 (Fax)
DUKE UNIVERSITY MEDICAL CENTER
2301 Erwin Rd STE 6TH, Durham 27705
(919) 668-4111 (Phone)
Duke University Md Ctr Card Srg
200 Trent Dr STE 2B, Durham 27710
(919) 681-4760 (Phone)
Duke University Health Services
2000 Erwin Rd STE 2B, Durham 27705
(919) 681-6432 (Phone)
1 Duke Medical Ctr, Durham 27710
(919) 684-8111 (Phone), (919) 681-8679 (Fax)
DUKE UNIVERSITY MEDICAL CENTER
2301 Erwin Rd STE 6TH, Durham 27705
(919) 668-4111 (Phone)
Duke University Md Ctr Card Srg
200 Trent Dr STE 2B, Durham 27710
(919) 681-4760 (Phone)
Duke University Health Services
2000 Erwin Rd STE 2B, Durham 27705
(919) 681-6432 (Phone)
Procedures:
Carotid Artery Stent Placement, Carotid Endarterectomy (CEA) or Excision of Infected Graft, Endovascular Repair of Aorta, Non-Coronary Angioplasty, Atherectomy, and Stenting
Conditions:
Aortic Aneurysm, Aortic Dissection, Carotid Artery Disease, Cerebral Artery Thrombosis, Cerebral Vascular Disease, Deep Vein Thrombosis (DVT), Peripheral Nerve Disorders, Renal Artery Arteriosclerotic Disease, Transient Ischemic Attack (TIA), Venous Embolism and Thrombosis
Certifications:
General Surgery, 2001, Vascular Surgery, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Durham Office
1 Duke Medical Ctr, Durham 27710
DUKE UNIVERSITY MEDICAL CENTER
2301 Erwin Rd STE 6TH, Durham 27705
Duke University Md Ctr Card Srg
200 Trent Dr STE 2B, Durham 27710
Duke University Health Services
2000 Erwin Rd STE 2B, Durham 27705
Duke University Hospital
2301 Erwin Rd, Durham 27710
Durham Regional Hospital
3643 North Roxboro Rd, Durham 27704
Southeastern Regional Medical Center
300 West 27Th St, Lumberton 28358
1 Duke Medical Ctr, Durham 27710
DUKE UNIVERSITY MEDICAL CENTER
2301 Erwin Rd STE 6TH, Durham 27705
Duke University Md Ctr Card Srg
200 Trent Dr STE 2B, Durham 27710
Duke University Health Services
2000 Erwin Rd STE 2B, Durham 27705
Duke University Hospital
2301 Erwin Rd, Durham 27710
Durham Regional Hospital
3643 North Roxboro Rd, Durham 27704
Southeastern Regional Medical Center
300 West 27Th St, Lumberton 28358
Education:
Medical School
Univ Of Vt Coll Of Med
Graduated: 1991
Duke University Med Center
Univ Of Vt Coll Of Med
Graduated: 1991
Duke University Med Center
Jeffrey H Lawson, Durham NC
Specialties:
Surgeon
Address:
4101 N Roxboro St, Durham, NC 27704
Duke University Medical Ctr, Durham, NC 27710
Duke University Medical Ctr, Durham, NC 27710
Education:
Doctor of Medicine
Board certifications:
American Board of Surgery Certification in Vascular Surgery (Surgery)
Jeffrey Lawson, Durham NC
Specialties:
Surgery, Vascular Surgery
Work:
Durham Va Medical Center
508 Fulton St, Durham, NC 27705 Private Diagnostic Clinic
3116 N Duke St, Durham, NC 27704
508 Fulton St, Durham, NC 27705 Private Diagnostic Clinic
3116 N Duke St, Durham, NC 27704
Education:
University of Vermont (1991)
Arteriovenous Graft For Hemodialysis With Puncture-Resistant Posterior And Side Walls
US Patent:
2014001, Jan 16, 2014
Filed:
Sep 16, 2013
Appl. No.:
14/027986
Inventors:
Jeffrey H. Lawson - Durham NC, US
Assignee:
Duke University - Durham NC
International Classification:
A61M 1/36
US Classification:
604 8
Abstract:
An arteriovenous dialysis access graft configured to be implanted in a subject includes: at least one flexible conduit having first and second end portions, wherein the first end portion is configured to connect to an artery of the subject and the second end portion is configured to connect to a vein of the subject such that blood flows through the at least one conduit; and at least one cannulation chamber positioned between the first end portion and the second end portion of the at least one conduit. The chamber includes: an elongated housing having an inlet and an outlet, a posterior wall, a pair of sidewalls, and an open anterior portion defining a cannulation port; and a self-sealing material extending across the cannulation port. The posterior wall and the sidewalls of the housing are formed of a substantially rigid material.
6-Peptidylamino-1-Naphthalenesulfonamides Useful As Fluorogenic Proteolytic Enzyme Substrates
US Patent:
5399487, Mar 21, 1995
Filed:
Mar 4, 1993
Appl. No.:
8/027294
Inventors:
Saulius Butenas - Burlington VT
Jeffrey H. Lawson - Durham NC
Kenneth G. Mann - Shelburne VT
Jeffrey H. Lawson - Durham NC
Kenneth G. Mann - Shelburne VT
Assignee:
Haematologic Technologies, Inc. - Essex Jct. VT
International Classification:
C12Q 156, C12Q 100, C07D27304, C07D25708
US Classification:
435 13
Abstract:
The present invention encompasses compounds of formula I: ##STR1## and the pharmaceutically acceptable non-toxic salts thereof; wherein R. sub. 1 is hydrogen, lower alkyl, alkenyl, alkynyl, cycloalkyl, alkylcycloalkyl, cycloalkylalkyl, or phenylalkyl;
R. sub. 2 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, alkylcycloalkyl, cycloalkylalkyl, or phenylalkyl; or
NR. sub. 1 R. sub. 2 forms a nitrogen heterocycle; and
R. sub. 3 is hydrogen, an amino acid or a peptide residue.
These compounds may be employed as substrates in assays for determining proteolytic enzyme activity or as enzyme inhibitors. The invention also encompasses methods for determining proteolytic enzyme activity using the compounds of formula I.
Method Of Inhibiting Smooth Muscle Proliferation
US Patent:
2003012, Jul 3, 2003
Filed:
Oct 2, 2002
Appl. No.:
10/262661
Inventors:
Walter Koch - Durham NC, US
Jeffrey Lawson - Durham NC, US
Jeffrey Lawson - Durham NC, US
Assignee:
DUKE UNIVERSITY
International Classification:
A61K048/00, A61K038/17
US Classification:
514/012000, 514/044000, 424/093200
Abstract:
The present invention relates, in general, to vascular smooth muscle proliferation and, in particular, to a method of inhibiting arterial and venous smooth muscle proliferation resulting, for example, from arterial injury, vein grafting or shunt implantation. The invention also relates to an expression construct encoding a G inhibitor suitable for use in such a method.